ART to Be Present at the Annual Conference of the American Association for Cancer Research (AACR) in Anaheim, California

2005-04-14

TSX - Toronto Stock Exchange · Silver · Gold · Zinc · Lead · Copper · Canada

MONTREAL, April 14 /CNW Telbec/ - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce its participation at the annual conference of the American Association for Cancer Research (AACR) being held at the Anaheim Convention Center in Anaheim, California, from April 16 to 20, 2005. ART will showcase the multiwavelength eXplore Optix(TM) system, a pre-clinical optical molecular imager designed to provide in vivo biodistribution and pharmacokinetics data, at the GE Healthcare booth (No. 787) located in the Exhibit Hall C and D of the Anaheim Convention Center.

About AACR

Founded in 1907, AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication and advocacy. AACR's annual meeting attracts more than 12,000 participants who share new and significant discoveries in the cancer field.

About ART

ART Advanced Research Technologies Inc. is a leader in optical molecular imaging products for the healthcare and pharmaceutical industries. ART has developed two products based on its innovative technology. The first is eXplore Optix(TM), a molecular imaging device designed for monitoring physiological changes in living systems at the preclinical study phases of new drugs. eXplore Optix(TM) is distributed by GE Healthcare and is used by industry and academic leaders worldwide to bring new and better treatments to patients faster. The second is SoftScan(R), a medical imaging device designed to improve the diagnosis and treatment of breast cancer. ART is commercializing its products in a global strategic alliance with GE Healthcare, a world leader in mammography and imaging. ART's shares are listed on the TSX under the ticker symbol ARA. Visit ART online at www.art.ca

This press release may contain forward-looking statements subject to risks and uncertainties that would cause actual events to differ materially from expectations. These risks and uncertainties are described in ART Advanced Research Technologies Inc.'s regulatory filings with Canadian Securities Commissions.